UNSPSC 51392402: Dobutamine

This classification denotes an adrenergic agent with the molecular formula C18H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3S12J47372, chemically known as 1,2-benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, (+-)- but generally known as dobutamine, which bears US NIH Compound Identifier 36811. European Medicines Agency schedules Dobutamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06343MIG.

UNSPSC 51392402 Dobutamine, a Commodity code, nominally identifies a specific pharmaceutical agent, but recent state and local solicitations tagged under this code are actually procuring naloxone and drug deactivation systems rather than dobutamine. Naloxone and drug deactivation systems represent emergency response supplies and opioid-overdose interventions deployed through county health departments and community health initiatives. The issuing bodies soliciting under this code include county government health agencies responsible for emergency medical response and public health infrastructure. The procurement pattern reflects state and local investment in overdose-reversal capability and controlled-substance disposal infrastructure as part of community health and emergency preparedness mandates.

Seminole County, Florida posted an IFB (Invitation for Bid) numbered IFB60459723LAS on June 30, 2026, seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building at 520 W. Lake Mary Blvd, Sanford, Florida, with a response deadline of July 26, 2023. The contract carries a two-year initial term with a one-year renewal option, includes a three-month probationary period, and is potentially funded through FEMA, imposing additional federal compliance requirements. Vendors must provide all shipping and delivery costs in their proposal, maintain workers' compensation and commercial general liability insurance, satisfy drug-free workplace and E-Verify requirements, and comply with the Clean Air Act and Federal Water Pollution Control Act. The code shows minimal recent activity; the mismatch between the nominal code name and the actual scope suggests that state and local procurement offices are applying this pharmaceutical classification to non-pharmaceutical overdose-response supplies, indicating either a data-entry error or category misalignment in the underlying solicitation tagging.